Copy of Notice Convening 43rd Annual General Meeting (AGM) of the Company will be held on Friday, 26 September, 2025 at 12:00 PM (IST) through Video Conferencing (VC)/ Other Audio Visual ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Coral Laboratories has called its 43rd AGM on Friday, September 26, 2025 at 12:00 PM via video conferencing. The board has recommended a dividend of Rs. 1.50 (15%) per equity share of Rs. 10 face value, totalling Rs. 53.59 lakh for FY25. Two directors — Mr. Girish Dhameja and Mr. Rajendrasinh Rana — are up for re-appointment by rotation. M/s. S C Mehra & Associates LLP is proposed as new statutory auditor for a 5-year term starting FY 2025-26, replacing the existing auditor. M/s. SARK & Associates LLP is proposed as Secretarial Auditor for 5 years (FY 2025-26 to FY 2029-30). Shareholders will also vote on altering the MOA to widen the company's pharmaceutical, veterinary and healthcare business scope, ratifying the cost auditor's fee of Rs. 2.73 lakh plus taxes for FY26, and approving remuneration for Mrs. Sushma Kadkade (up to Rs. 30 lakh per annum) and Ms. Meera Doshi (up to Rs. 5 lakh per month for 3 years from October 2025).
The proposed 15% dividend continues the company's regular payout record, offering modest income to shareholders. Auditor changes, director re-appointments and cost auditor ratification are routine governance items and unlikely to move the stock. The MOA amendment signals an intent to broaden the pharmaceutical and animal healthcare business, which could support future expansion if approvals are secured.